NM-23 gene loss of heterozygosity and protein expression in high-stage laryngeal squamous cell carcinomas

Diagnostic Molecular Pathology

Volumn 15, Issue 1, 2006, Pages 1-6

  Sheikh, Hina ^a   Murphy, Justin ^a   Hunt, Jennifer L ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

Laryngeal carcinoma; NM 23; Squamous cell carcinoma; Tumor metastasis genes

Indexed keywords

ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORESIS; FEMALE; FOLLOW UP; GENE LOCUS; HEAD AND NECK CARCINOMA; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; MARKER GENE; METASTASIS; NM23 GENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; LARYNGEAL NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE;

EID: 33645668861     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200603000-00001     Document Type: Article

References (33)

1. Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112:1970-1974.
2. Hoffman HT. Surgical treatment of cervical node metastases from squamous cell carcinoma of the upper aerodigestive tract: evaluation of the evidence for modifications of neck dissection. Head Neck. 2001;23:907-915.
3. Ford AC, Grandis JR. Targeting epidermal growth factor receptor in head and neck cancer. Head Neck. 2003;25:67-73.
4. Albertazzi E, Cajone F, Leone BE, et al. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression. DNA Cell Biol. 1998;17:335-342.
5. Brenner AS, Thebo JS, Senagore AJ, et al. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer. Am Surg. 2003;69:203-208; discussion 208.
6. Kauffman EC, Robinson VL, Stadler WM, et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site [comment]. J Urol. 2003;169:1122-1133.
7. Hailat N, Keim DR, Melhem RF, et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage and with n-myc gene amplification. J Clin Invest. 1991;88:341-345.
8. Kapranos N, Karaiossifidi H, Kouri E, et al. Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients. Anticancer Res. 1996;16:3987-3990.
9. Pavelic B, Kapitanovic S, Radosevic S, et al. Increased activity of nm-23H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis. J Mol Med. 2000;78:111-118.
10. Campo E, Miquel R, Jares P, et al. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer. 1994;73:2913-2921.
11. Seifert M, Theisinger B, Engel M, et al. Isolation and characterization of new microsatellites at the nm23-H1 and nm23-H2 gene loci and application for loss of heterozygosity (LOH) analysis. Hum Genet. 1997;100:515-519.
12. Otsuki K, Alcalde RE, Matsumura T, et al. Immunohistochemical analysis of nucleoside diphosphate kinases in oral squamous cell carcinomas. Oncology. 1997;54:63-68.
13. Wang Q, Guo ML. [Study on expression of nm23-H1 gene in laryngeal cancer tissues]. Chung Hua Erh Pi Yen Hou Ko Tsa Chih. Chinese Journal of Otorhinolaryngology. 1996;31:198-200.
14. Slebos RJ, Umbach DM, Sommer CA, et al. Analytical and statistical methods to evaluate microsatellite allelic imbalance in small amounts of DNA. Lab Invest. 2004;84:649-657.
15. Wang YF, Chow KC, Chang SY, et al. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer. 2004;90:2186-2193.
16. Fleming ID, Cooper HS, Hensen DE, et al. AJCC Cancer Staging Manual. Philadelphia, PA: Lippincott-Raven; 1997.
17. Hunt JL, Baloch ZW, LiVolsi VA. Sentinel lymph node evaluation for tumor metastasis. Semin Diagn Pathol. 2002;19:263-277.
18. Stoeckli S, Pfaltz M, Steinert H, et al. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope. 2002;112:111-115.
19. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2003;260:502-508.
20. Jin Y, Jin C, Wennerberg J, et al. Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21-q29 in head and neck carcinomas. Int J Cancer. 2002;98:475-479.
21. Nadal A, Cardesa A. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch. 2003;442:1-7.
22. Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope. 2002;112:472-481.
23. Huang SM, Li JPM. Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Mol Cancer Ther. 2002;1:507-514.
24. Matheny KE, Barbieri CE, Sniezek JC, et al. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells. Laryngoscope. 2003;113:936-939.
25. Backer JM, Mendola CE, Kovesdi I, et al. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene. 1993;8:497-502.
26. Steeg PS, Bevilacqua G, Pozzatti R, et al. Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res. 1988;48:6550-6554.
27. Engel M, Theisinger B, Seib T, et al. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int J Cancer. 1993;55:375-379.
28. Royds JA, Cross SS, Silcocks PB, et al. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma. J Pathol. 1994;172:261-266.
29. Royds JA, Stephenson TJ, Rees RC, et al. Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst. 1993;85:727-731.
30. Kapitanovic S, Cacev T, Berkovic M, et al. nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma. J Clin Pathol. 2004;57:1312-1318.
31. Suzuki E, Ota T, Tsukuda K, et al. nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int J Cancer. 2004;108:207-211.
32. Fischbach MA, Settleman J. Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase. Cancer Res. 2003;63:4089-4094.
33. Viel A, Dall'Agnese L, Canzonieri V, et al. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Cancer Res. 1995;55:2645-2650.